Skip to main content
OpenTrials

Clinical trial condition

Genital Diseases, Female

Explore clinical trials studying Genital Diseases, Female. Study availability and eligibility vary by location and protocol.

7,700 public trials 1,520 recruiting studies
Refine in advanced search Browse all conditions

Genital Diseases, Female trial results

Completed

Cross-Shaped Vaginal Pessary for Pelvic Organ Prolapse

NCT07554651

Conditions
Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Genital Diseases, +12 more
Locations
  • City Clinical Hospital No. 6, Dnipro City Council Dnipro, Ukraine
  • Clinical Hospital of Emergency Medical Care, Dnipro City Council Dnipro, Ukraine
  • City Out-Patient Clinic No. 18, Kharkiv City Council Kharkiv, Ukraine
  • Regional Clinical Hospital, Poltava Regional Council Poltava, Ukraine
View Trial Details
Completed

Nonavalent Prophylactic HPV Vaccine (GARDASIL9) After Local Conservative Treatment for Cervical Intra-epithelial Neoplasia

NCT03979014

Conditions
Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Genital Diseases, +11 more
Locations
  • Helsinki University Hospital Helsinki, Finland
  • Tampere University Hospital Tampere, Finland
  • Regionhälsan Masthugget Clinic of Obstetrics and Gynecology Gothenburg, Sweden
  • Sahlgrenska University Hospital Gothenburg, Sweden
View all 13 locations
View Trial Details
Completed

Efficacy and Safety of Pembrolizumab (MK-3475) Plus Lenvatinib (E7080/MK-7902) in Previously Treated Participants With Select Solid Tumors (MK-7902-005/E7080-G000-224/LEAP-005)

NCT03797326

Conditions
Adnexal Diseases, Advanced Solid Tumors, Astrocytoma, +49 more
Locations
  • City of Hope ( Site 0002) Duarte, California, United States
  • Cedars Sinai Medical Center ( Site 0003) Los Angeles, California, United States
  • University of California Davis Comprehensive Cancer Center ( Site 0005) Sacramento, California, United States
  • University of Colorado, Anschutz Cancer Pavilion ( Site 0007) Aurora, Colorado, United States
View all 88 locations
View Trial Details
Completed

Study of Chemotherapy With Pembrolizumab (MK-3475) Followed by Maintenance With Olaparib (MK-7339) for the First-Line Treatment of Women With BRCA Non-mutated Advanced Epithelial Ovarian Cancer (EOC) (MK-7339-001/KEYLYNK-001/ENGOT-ov43/GOG-3036)

NCT03740165

Conditions
Abdominal Neoplasms, Adnexal Diseases, Digestive System Diseases, +22 more
Locations
  • University of Alabama at Birmingham (UAB) ( Site 0036) Birmingham, Alabama, United States
  • University of Arizona Cancer Center ( Site 0074) Tucson, Arizona, United States
  • Disney Family Cancer Center ( Site 0042) Burbank, California, United States
  • Kaiser Permanente Oncology Clinical Trial -Oakland ( Site 0077) Oakland, California, United States
View all 227 locations
View Trial Details

Related conditions